Autotaxin inhibitor 12

CAS No. 1613513-14-6

Autotaxin inhibitor 12 ( —— )

Catalog No. M12344 CAS No. 1613513-14-6

Autotaxin inhibitor 12 is a highly potent, selective, orally-bioavailable inhibitor of autotaxin with IC50 of 3.1 nM in choline release assays.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Autotaxin inhibitor 12
  • Note
    Research use only, not for human use.
  • Brief Description
    Autotaxin inhibitor 12 is a highly potent, selective, orally-bioavailable inhibitor of autotaxin with IC50 of 3.1 nM in choline release assays.
  • Description
    Autotaxin inhibitor 12 is a highly potent, selective, orally-bioavailable inhibitor of autotaxin with IC50 of 3.1 nM in choline release assays; shows ATX inhibition of IC50 9 nM in an in vitro serum assay, measuring 18:1 LPA levels by LCMS; concentration-dependently inhibits autotaxin and formation of LPA in vivo.
  • Synonyms
    ——
  • Pathway
    Wnt/Notch/Hedgehog
  • Target
    Autotaxin
  • Recptor
    Autotaxin
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1613513-14-6
  • Formula Weight
    440.33
  • Molecular Formula
    C19H23Cl2N5O3
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    C1CN(CCC1NC(=O)CCCC2=NNN=C2)C(=O)OCC3=CC(=CC(=C3)Cl)Cl
  • Chemical Name
    3,5-dichlorobenzyl 4-(4-(1H-1,2,3-triazol-4-yl)butanamido)piperidine-1-carboxylate

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Thomson CG, et al. Bioorg Med Chem Lett. 2018 May 21. pii: S0960-894X(18)30431-1.
molnova catalog
related products
  • HA-130

    A potent and selective inhibitor of autotaxin with IC50 of 28 nM.

  • PAT-048

    PAT-048 (PAT048) is apotent, selective, noncompetitive autotaxin inhibitor with IC50 of 1.1 nM against the lysoPLD activity of human ATX.

  • GLPG-1690

    GLPG-1690 (Ziritaxestat, GLPG1690) is a first-in-class, potent, competitive autotaxin inhibitor with Ki/IC50 of 15 nM/131 nM.